Glucotrack delisted by Nasdaq after $0.87 close violates bid-price exception; trading halted Oct 30

Glucotrack, Inc.

Nasdaq Hearings Panel required a closing bid of at least $1.00 every trading day through November 9, 2026; company closed at $0.87 on October 14, 2026.
Trading in Glucotrack common stock (GCTK) on Nasdaq will be suspended at the open of trading on October 30, 2026.
Nasdaq expected to file Form 25 to delist the securities and deregister them under Section 12(b) of the Exchange Act.
Company plans for its shares to be quoted on the OTC Markets OTCID tier and intends to submit an application to trade there.
Prior delisting determination was for failure to meet Nasdaq Listing Rule 5550(a)(2) $1.00 minimum bid price requirement.

Featured in Daily 8-K Digest

Selected #1 for 2026-10-29. Read digest

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.